DXCM

MKT CAP:$28B

DexCom Inc

Market Cap

$28B

Healthcare·Medical Devices·🇺🇸 United States·NASDAQ

Healthcare·Medical Devices·🇺🇸·NASDAQ

Stock Price

$76.62+$10.08 (+15.15%)

Jun 8, 2026

52W High $89.5352W Low $54.84

Company Details

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. T...

CEO

—

IPO Date

Apr 14, 2005

Website

www.dexcom.com

Key Metrics TTM

Revenue

$4.8B

+16.1% YoY

Net Income

$930M

EPS (Diluted)

Free Cash Flow

$1.4B

Revenue / Share

$12.24

Gross Margin

61.8%

Operating Margin

21.4%

Net Margin

19.3%

FCF Margin

29.7%

P/S

5.9x

P/E

30.6x

Earnings Reports

Q2 2026

Jul 29, 2026

PENDING

Q1 2026

Apr 30, 2026

$1.2B+15.0%

FY 2025

Feb 12, 2026

$4.7B+15.6%

Q4 2025

Feb 12, 2026

$1.3B+13.1%

Q3 2025

Oct 30, 2025

$1.2B+21.6%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee